Treatment of Myelodysplastic Syndromes with AML-Type Chemotherapy
- 1 January 1993
- journal article
- clinical trial
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 11 (sup2) , 59-63
- https://doi.org/10.3109/10428199309064263
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy.Journal of Clinical Oncology, 1993
- Fludarabine and Arabinosylcytosine Therapy of Refractory and Relapsed Acute Myelogenous LeukemiaLeukemia & Lymphoma, 1993
- Refractory anemia with excess of blasts in transformation hematologic and clinical study of 52 patientsCancer, 1989
- Aggressive chemotherapy in adult primary myelodysplastic syndromesAnnals of Hematology, 1988
- The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromesBritish Journal of Haematology, 1986
- LithotripsyAnnals of Internal Medicine, 1985
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemiaBlood, 1980
- Acute LeukemiaJAMA, 1974
- Smoldering Acute LeukemiaNew England Journal of Medicine, 1963